Literature DB >> 10516760

Perillyl alcohol selectively induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed myeloid cell lines.

M B Sahin1, S M Perman, G Jenkins, S S Clark.   

Abstract

The Bcr/Abl tyrosine kinase that is expressed from the Philadelphia chromosome protects leukemia cells from apoptosis caused by removal of growth factors or by cytotoxic agents and ionizing irradiation. This resistance to apoptosis is associated with a Bcr/Abl-mediated G2/M delay. Therefore, inhibiting Bcr/Abl signaling pathways should block the ability of the Bcr/Abl kinase to protect cells from apoptosis. The monoterpenes, limonene and perillyl alcohol (POH) are new anticancer agents that selectively induce apoptosis in neoplastic cells of a variety of rodent carcinoma models. Since the potential antitumor activities of monoterpenes overlap with signaling pathways affected by the Bcr/Abl kinase, POH and limonene were tested for antileukemia activity. POH, but not limonene selectively induced G0/G1 arrest followed by apoptosis in Bcr/Abl-transformed, but not nontransformed FDC.P1 and 32D myeloid cell lines. In contrast to their greater sensitivity to POH, Bcr/Abl-transformed cells were more resistant than nontransformed cells to several chemotherapy agents and ionizing irradiation. Since in Bcr/Abl-transformed cells, POH induces apoptosis associated with G0/G1 arrest, POH must activate an apoptotic pathway that is not protected by the Bcr/Abl-induced G2/M delay. Monoterpenes may represent novel agents for treating Ph+ leukemias.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516760     DOI: 10.1038/sj.leu.2401536

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  9 in total

1.  A non-coding cationic lipid DNA complex produces lasting anti-leukemic effects.

Authors:  Nikki Keasey; Zachary Herse; Stella Chang; Denny H Liggitt; Marla Lay; Jeffery Fairman; David F Claxton
Journal:  Cancer Biol Ther       Date:  2010-09-13       Impact factor: 4.742

Review 2.  Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.

Authors:  Thomas C Chen; Clovis O Da Fonseca; Axel H Schönthal
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  Synthesis of novel perillyl-dihydropyrimidinone hybrids designed for antiproliferative activity.

Authors:  Vinicius Vendrusculo; Vanessa P de Souza; Luiz Antônio M Fontoura; Marcelo G M D'Oca; Thais P Banzato; Paula A Monteiro; Ronaldo A Pilli; João Ernesto de Carvalho; Dennis Russowsky
Journal:  Medchemcomm       Date:  2018-07-31       Impact factor: 3.597

Review 4.  Isoprenoids: remarkable diversity of form and function.

Authors:  Sarah A Holstein; Raymond J Hohl
Journal:  Lipids       Date:  2004-04       Impact factor: 1.880

5.  Repurposing L-Menthol for Systems Medicine and Cancer Therapeutics? L-Menthol Induces Apoptosis through Caspase 10 and by Suppressing HSP90.

Authors:  Uzma Faridi; Sunita S Dhawan; Shaifali Pal; Sanchita Gupta; Ashutosh K Shukla; Mahendra P Darokar; Ashok Sharma; Ajit K Shasany
Journal:  OMICS       Date:  2016-01

Review 6.  Molecular mechanisms involved in farnesol-induced apoptosis.

Authors:  Joung Hyuck Joo; Anton M Jetten
Journal:  Cancer Lett       Date:  2009-06-10       Impact factor: 8.679

7.  Effects of POH in combination with STI571 on the proliferation and apoptosis of K562 cells.

Authors:  Yan Chen; Dong Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

Review 8.  Antitumor activity of monoterpenes found in essential oils.

Authors:  Marianna Vieira Sobral; Aline Lira Xavier; Tamires Cardoso Lima; Damião Pergentino de Sousa
Journal:  ScientificWorldJournal       Date:  2014-10-14

Review 9.  The Wonderful Activities of the Genus Mentha: Not Only Antioxidant Properties.

Authors:  Majid Tafrihi; Muhammad Imran; Tabussam Tufail; Tanweer Aslam Gondal; Gianluca Caruso; Somesh Sharma; Ruchi Sharma; Maria Atanassova; Lyubomir Atanassov; Patrick Valere Tsouh Fokou; Raffaele Pezzani
Journal:  Molecules       Date:  2021-02-20       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.